Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$752.64M
Total Bought:
$3.08M
Total Sold:
$169.57M
Net Transaction:
-$166.49M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,896,4624,896,4620$213.68M$277.14M36.82%+$63.46M
Disc Medicine, Inc.(IRON)2,384,4562,142,617-241,839$126.28M$141.58M18.81%+$15.30M
Dyne Therapeutics, Inc.(DYN)9,130,4659,130,4650$86.92M$115.50M15.35%+$28.58M
Sionna Therapeutics, Inc.(SION)3,694,0203,615,527-78,493$64.09M$106.33M14.13%+$42.24M
Korro Bio, Inc.(KRRO)1,137,1491,137,1490$14.20M$54.46M7.24%+$40.26M
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,2570$41.80M$45.33M6.02%+$3.54M
Generation Bio, Co.8,279,484827,946-7,451,538$2.65M$5.07M0.67%+$2.42M
Q32 Bio Inc.(QTTB)2,092,1062,092,1060$3.12M$4.14M0.55%+$1.03M
ImageneBio, Inc.(IMA)0377,814+377,814$0$3.08M0.41%+$3.08M
Ikena Oncology, Inc.5,018,1780-5,018,178$6.72M$0—-$6.72M
Third Harmonic Bio, Inc.10,402,2860-10,402,286$56.48M$0—-$56.48M
Vigil Neuroscience, Inc.5,836,8740-5,836,874$46.40M$0—-$46.40M
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q3 2025 | TickerTrail